Related Experiment Video
Updated: Aug 23, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells
Susumu Watanabe1, Wei Mu, Andrew Kahn
1Baylor College of Medicine, Houston, Tex., USA. susumuw@showa-university-fujigaoka.gr.jp
Background/Aims:
IL-6, an inducer of the acute-phase response, is linked with the development of vascular disease and atherosclerosis. One mechanism likely involves direct effects of IL-6 on vascular smooth muscle cells (VSMC), for IL-6 can induce VSMC proliferation and the release of monocyte chemoattractant protein-1 (MCP-1). We hypothesized that this stimulation occurs via the JAK (janus-activated kinase)/STAT (signal and transducers and activators of transcription) signaling pathway.
Methods:
Rat VSMC were stimulated with IL-6 in the presence or absence of a JAK 2 inhibitor, and the activation of STAT 3 (by Western), MCP-1 (by ELISA) and DNA synthesis (by (3)H-thymidine incorporation) was determined.
Results:
IL-6 rapidly induced phosphorylation of STAT 3 in a dose- and time-dependent manner with a peak expression at 30 min. IL-6 also stimulated MCP-1 protein production and DNA synthesis dose dependently. 50 microM of AG490, a specific JAK 2 inhibitor, partially inhibited STAT 3 activation and MCP-1 production, with near complete inhibition of DNA synthesis.
Conclusion:
The JAK/STAT pathway partially mediates IL-6-induced MCP-1 production and DNA synthesis in rat VSMC. These studies implicate a role of the JAK/STAT pathway in the development of vascular disease and atherosclerosis.
Insights
Interleukin-6 (IL-6) stimulates vascular smooth muscle cell proliferation and MCP-1 release via the JAK/STAT pathway. This pathway partially mediates IL-6 effects, suggesting a role in vascular disease development.
Area of Science:
- Vascular Biology
- Cell Signaling
- Immunology
Background:
- Interleukin-6 (IL-6) is implicated in vascular disease and atherosclerosis.
- IL-6 directly affects vascular smooth muscle cells (VSMC), inducing proliferation and monocyte chemoattractant protein-1 (MCP-1) release.
- The janus-activated kinase (JAK)/signal and transducers and activators of transcription (STAT) pathway is a potential mediator of IL-6 effects.
Purpose of the Study:
- To investigate the role of the JAK/STAT signaling pathway in mediating IL-6-induced responses in VSMC.
- To determine if JAK/STAT pathway activation is necessary for IL-6-stimulated VSMC proliferation and MCP-1 production.
Main Methods:
- Rat VSMC were treated with IL-6.
- JAK 2 inhibitor (AG490) was used to block JAK/STAT signaling.
- STAT 3 activation (Western blot), MCP-1 production (ELISA), and DNA synthesis ((3)H-thymidine incorporation) were measured.
Main Results:
- IL-6 induced rapid, dose- and time-dependent STAT 3 phosphorylation.
- IL-6 stimulated MCP-1 protein production and DNA synthesis.
- AG490 partially inhibited STAT 3 activation and MCP-1 production, but nearly completely inhibited DNA synthesis.
Conclusions:
- The JAK/STAT pathway partially mediates IL-6-induced MCP-1 production and DNA synthesis in VSMC.
- These findings highlight the JAK/STAT pathway's role in the pathogenesis of vascular disease and atherosclerosis.
Related Concept Videos
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades